Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices

Histology and Histopathology

Volumn 15, Issue 3, 2000, Pages 667-672

  Goussia, A C ^a   Ioachim, E ^a   Agnantis, N J ^a   Mahera, M ^a   Tsianos, E V ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Bcl 2; Colorectal tumours; mdm 2; p53; Rb

Indexed keywords

KI 67 ANTIGEN; PROTEIN; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P53;

ADENOCARCINOMA; ADENOMA; ARTICLE; CARCINOGENESIS; COLORECTAL TUMOR; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADENOMA; CELL DIVISION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033912421     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Apoptosis and Immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance
2. Molecular genetics of cancer
3. Bcl-2 expression and the development of endometrial carcinoma
4. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers
5. Expression of bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon
6. Wild-type p53 can down-modulate the activity of various promoters
7. Bcl-2 expression in human colorectal adenomas and carcinomas
8. Down-regulation of bcl-2 by p53 in breast cancer cells
9. Proliferation cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms
10. Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence
11. Imbalance between proliferation and apoptosis in the development of colorectal carcinoma
12. Expression and prognostic significance of Bcl-2 in ovarian tumours
13. Bcl-2 expression is topographically restricted in tissues characterised by apoptotic cell death
14. The role of the p53 and Rb-1 genes in cancer, development and apoptosis
15. Genetic prognostic markers in colorectal cancer
16. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familiar adenomatous polyposis (FAP)
17. Expression of bcl-2 in small cell carcinoma cells
18. Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach
19. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
20. Cell division versus cell death: A functional model of multistep neoplasia
21. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
22. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: Correlation with tumour stage and patient survival
23. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland
24. Bcl-2 and the regulation of programmed cell death
25. Bcl-2 and B-cell neoplasia, dysregulation of programmed cell death in cancer
26. The Bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients
27. Bcl-2 and p53 oncoprotein expression during colorectal carcinogenesis
28. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas
29. Involvement of the bcl-2 gene in human follicular lymphoma
30. Mechanisms of bcl-2 function
31. Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas
32. The p53-mdm-2 autoregulatory feedback loop
33. Villous tumor of the colon and rectum with special reference to roles of p53 and bcl-2 in adenoma-carcinoma sequence